TRT personal experience videos: what the science says vs. what you'll hear

What did @popethecoach actually say?

In week 11 of his TRT journey, @popethecoach reports his dose was increased from 160mg per week (80mg twice weekly) to 200mg per week (100mg twice weekly). He says he has gained 16 pounds since starting, now sitting at 176 pounds, and wonders aloud whether "my appetite has increased since I increased my dosage." He frames everything as personal experience, not advice, and invites both experts and beginners to comment.

To his credit, he is transparent about the timeline, the specific milligram numbers, and the fact that he has only been on the new dose for one week. That level of specificity is more useful than most TRT content floating around TikTok, where vague "I just feel amazing" posts dominate.

Does the science back this up?

The 16-pound weight gain over roughly 11 weeks is plausible but almost certainly not all muscle. Research is pretty clear on this. Studies show that supraphysiologic or high-normal testosterone increases lean mass, but a meaningful portion of early weight gain on TRT is water retention driven by estradiol conversion and sodium retention.

Bhasin et al. (2001, New England Journal of Medicine) demonstrated dose-dependent increases in lean body mass with testosterone, but even at 600mg per week, fat-free mass gains over 20 weeks averaged around 7-8 pounds in non-exercising men. Sixteen pounds in 11 weeks at 160-200mg weekly would require substantial water retention or significant caloric surplus, which his mention of increased appetite hints at. The appetite observation is also biologically grounded. Testosterone influences ghrelin and leptin signaling, and there is emerging evidence (Skibicka et al., 2012, Endocrinology) linking androgen receptor activity to appetite regulation, though direct causation in TRT patients at these doses is not firmly established in large trials.

What did they get wrong (or right)?

He got the self-awareness right. Saying "I don't expect any major changes" one week into a dose increase shows a reasonable understanding of testosterone pharmacokinetics. Testosterone cypionate, a common TRT ester, has a half-life of roughly 8 days, meaning stable serum levels at a new dose take 4-5 half-lives, or about 5-6 weeks, to fully establish. One week in, blood levels are still climbing.

What he glosses over is the significance of the dose itself. Two hundred milligrams per week is at the high end of what most endocrinology guidelines consider replacement therapy. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) target total testosterone levels of 400-700 ng/dL for hypogonadal men. Whether 200mg weekly achieves that or overshoots into supraphysiologic territory depends entirely on individual metabolism, which he does not mention. He also says nothing about estradiol management, hematocrit monitoring, or any bloodwork, all of which become more relevant as doses climb.

What should you actually know?

If you are watching this video and thinking about your own TRT dose, here is what @popethecoach's experience cannot tell you: how his bloodwork looks. Weight gain and appetite changes are observable, but the risks that matter at higher TRT doses, elevated hematocrit, erythrocytosis, cardiovascular strain, and estradiol imbalance, are invisible without lab testing.

The cardiovascular question is not trivial. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), the largest randomized trial of testosterone therapy to date, found no significant increase in major adverse cardiovascular events in hypogonadal men with pre-existing cardiovascular risk, but that was at doses targeting physiologic replacement levels, not at the higher end of the dosing range. Extrapolating from his n-of-1 experience to your situation is a mistake.

• Sixteen pounds of weight gain in 11 weeks warrants a conversation about body composition testing, not just scale weight.
• Injection site redness, which he mentions casually, can indicate improper technique, infection risk, or allergic reaction to the carrier oil and should be evaluated if persistent.
• Dose escalation decisions should be driven by bloodwork, not by how someone feels subjectively.

Bottom line

@popethecoach is doing what a lot of TRT content creators do: sharing a real experience in real time with reasonable honesty about what he does and does not know. That has value. He is not selling anything here, and he is not claiming his results are universal. But the video has no bloodwork, no discussion of monitoring, and no mention of what "low testosterone" actually meant for him clinically. Those gaps matter. His gains are plausible. His approach to dose escalation raises questions he never addresses.